-+ 0.00%
-+ 0.00%
-+ 0.00%

JAZZ PHARMACEUTICALS: IN CONNECTION WITH ACTIO BIOSCIENCES ACQUISITION, ESTIMATES Q3 2026 GAAP & NON-GAAP PRE-TAX IPR&D CHARGE OF $755 MLN

Reuters·10/26/2026 20:15:45